Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003358324 | SCV004053116 | uncertain significance | Cardiovascular phenotype | 2023-07-30 | criteria provided, single submitter | clinical testing | The p.T350N variant (also known as c.1049C>A), located in coding exon 2 of the JPH2 gene, results from a C to A substitution at nucleotide position 1049. The threonine at codon 350 is replaced by asparagine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |